↓ Skip to main content

The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessments

Overview of attention for article published in Trials, March 2011
Altmetric Badge

Mentioned by

twitter
1 X user
facebook
1 Facebook page

Citations

dimensions_citation
105 Dimensions

Readers on

mendeley
207 Mendeley
connotea
1 Connotea